The Inscripta™ Blog
March 16, 2021
A New Digital Experience for Genome Engineering
As we designed the Onyx™ platform for automated genome engineering, we challenged ourselves to break free from the usual instrumentation and…
March 9, 2021
Scientists Deploy MAD7 Enzyme for Mammalian Genome Edits
Even before we launched our benchtop Onyx™ platform for automated genome engineering, the Inscripta team had already made progress in addressing…
March 2, 2021
Inside Inscripta: Patrick Westfall, Microbe
As we continue profiling members of the Inscripta team, we’re delighted to chat with Patrick Westfall, Senior Director, Microbe. The Illinois…
February 25, 2021
Onyx Platform Multiplexing Makes Full Saturation Protein Mutagenesis Possible
Picture it: You want to investigate your favorite biological phenomenon, and you start with a screening strategy that results in a number of…
February 16, 2021
Tackling Challenges in Today’s CRISPR Workflows
With so much enthusiasm around CRISPR gene editing, it’s all too easy to sweep aside those nagging concerns about technical implementation. But…
February 10, 2021
Inside Inscripta: Deanna Church, Mammalian Business Area
We hope you’re enjoying our employee profile series! Today we have the pleasure of catching up with Deanna Church, Vice President for Mammalian…
February 2, 2021
How Inscripta Technology Accelerates Adaptive Laboratory Evolution Experiments
While adaptive laboratory evolution (ALE) is a powerful approach for developing microbial strains that thrive in challenging growth…
January 26, 2021
Genome Engineering Trends in 2021
The long-awaited 2021 is still in its infancy, but we’re so excited about what’s in store this year — most notably, of course, the COVID-19…
January 20, 2021
Onyx Platform Helps Synthetic Cannabis Company Create Its First Commercial Product
You may have heard of the cannabis compounds THC and CBD, but did you know there are more than 100 cannabinoids, many of which could have…